24.08.2023

The annual Danish honorary grant ‘Højesteretssagfører Kaj Bunch-Jensen og Allis Bunch-Jensens Legat’ was awarded Professor Kari Tanderup August 24 at the Danish Centre for Particle Therapy. The grant honours remarkable Danish cancer researchers.

The grant is awarded annually to a worthy Danish scientist within cancer research or blood pressure research with the aim of supporting research within these areas of medicine. The grant consists of a prize of DKK 100.000 for Kari Tanderups research and DKK 25.000 as a personal honorary grant.

Kari Tanderups research covers the field of developing individualised radiotherapy for cervical cancer, clinical results and research within side effects and the influence on patients’ quality of life.

’Professor Kari Tanderup is an internationally acknowledged researcher in medical physics and radiotherapy, especially within treatment of cervical cancer, where she has accomplished highly significant contributions on both external and internal radiotherapy (brachytherapy) and on side effects and late effects,’ explains Lena Specht, consultant, M.D., professor in Oncology at Rigshospitalet on the background for the grant presentation.   

Kari Tanderup became a professor of medical physics at Aarhus University Hospital (AUH) in 2014 and subsequently at the Danish Centre for Particle Therapy, but her career at AUH already started in 1998, where she worked as a medical physicist at the Oncology Department until 2003. In 2007, Kari Tanderup received her PhD degree and has since then proved to be a research beacon in Denmark and internationally with +200 publications, as a supervisor for many science aspirants and as a coordinator of large international studies in EMBRACE.

’I am very thankful for the notable recognition of research results from the big international network, EMBRACE, that I work within. I would like to thank the foundation for the appreciation of interdisciplinary collaboration, where e.g. physicists, physicians, nurses, radiographers and psychologists pull together’, says Kari Tanderup.

The research grant will be applied to set a new clinical trial for cervical cancer patients in motion, where women with a good prognosis are offered treatment with a lower radiation dose to reduce the risk of chronic side effects.

Read more about Kari Tanderups research group.